Related Experiment Video
Updated: Feb 10, 2026

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE
Published on: March 1, 2024
Emerging Infectious Diseases, Antimicrobial Resistance and Millennium Development Goals: Resolving the Challenges
G V Asokan1, R K Kasimanickam2
1Public Health Program, College of Health Sciences, University of Bahrain, Manama, Bahrain.
Abstract:
Most emerging infectious diseases are zoonoses, which could severely hamper reaching the targets of millennium development goals (MDG). Five out of the total eight MDG's are strongly associated with the Emerging Infectious Diseases (EIDs). Recent emergence and dissemination of drug-resistant pathogens has accelerated and prevent reaching the targets of MDG, with shrinking of therapeutic arsenal, mostly due to antimicrobial resistance (AMR). World Health Organization (WHO has identified AMR as 1 of the 3 greatest threats to global health. Until now, methicillin-resistant staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE) have been observed in hospital-acquired infections. In India, within a span of three years, New Delhi metallo-β-lactamase prevalence has risen from three percent in hospitals to twenty- fifty percent and is found to be colistin resistant as well. Routine use of antimicrobials in animal husbandry accounts for more than 50% in tonnage of all antimicrobial production to promote growth and prophylaxis. This has consequences to human health and environmental contamination with a profound impact on the environmental microbiome, resulting in resistance. Antibiotic development is now considered a global health crisis. The average time required to receive regulatory approval is 7.2 years. Moreover, the clinical approval success is only 16%. To overcome resistance in antimicrobials, intersectoral partnerships among medical, veterinary, and environmental disciplines, with specific epidemiological, diagnostic, and therapeutic approaches are needed. Joint efforts under "One Health", beyond individual professional boundaries are required to stop antimicrobial resistance against zoonoses (EID) and reach the MDG.
Insights
Emerging infectious diseases, often zoonoses, threaten global health and Millennium Development Goals (MDG). Antimicrobial resistance (AMR) is a major challenge, requiring intersectoral "One Health" approaches to combat resistance in zoonotic diseases.
Area of Science:
- Public Health
- Infectious Diseases
- Microbiology
Background:
- Emerging infectious diseases (EIDs), primarily zoonoses, significantly impede progress towards Millennium Development Goals (MDGs).
- Antimicrobial resistance (AMR) is a critical global health threat, exacerbated by drug-resistant pathogens and a shrinking therapeutic arsenal.
- Specific concerns include hospital-acquired infections by methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococci (VRE), and rising New Delhi metallo-β-lactamase (NDM) prevalence in India.
Purpose of the Study:
- To highlight the impact of zoonotic EIDs and AMR on achieving MDGs.
- To underscore the challenges in antibiotic development and regulatory approval.
- To advocate for intersectoral collaboration under the "One Health" framework to combat AMR.
Main Methods:
- Review of current trends in emerging infectious diseases and antimicrobial resistance.
- Analysis of the impact of antimicrobial use in animal husbandry on human health and the environment.
- Examination of the antibiotic development pipeline and regulatory success rates.
Main Results:
- Five of eight MDGs are strongly linked to EIDs.
- Antimicrobial use in livestock for growth promotion and prophylaxis contributes significantly to AMR and environmental contamination.
- Antibiotic development faces a lengthy approval process (7.2 years) with low clinical success rates (16%).
Conclusions:
- Addressing AMR requires integrated, interdisciplinary strategies involving medical, veterinary, and environmental sectors.
- The "One Health" approach is essential for controlling antimicrobial resistance in zoonotic EIDs and achieving global health targets.
- Urgent action is needed to overcome the global health crisis posed by antibiotic resistance.
More Related Videos
09:29In Vivo Investigation of Antimicrobial Blue Light Therapy for Multidrug-resistant Acinetobacter baumannii Burn Infections Using Bioluminescence Imaging
Published on: April 28, 2017
14:34Biocontained Carcass Composting for Control of Infectious Disease Outbreak in Livestock
Published on: May 6, 2010
Related Concept Videos
Development of Antibiotic Resistance
Psychosis: Goals of Pharmacotherapy
Emerging Adulthood
Antimicrobial Effectiveness
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Introduction Cardiac Emergencies